NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/10/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization15.24 mln
Float24.04 mln
Earnings Date07/14/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-3.43
Reliable
Relative Strength
94
/ 100
Top performer
Debt / Equity
0.01
Debt-free
ROE
-175
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Lexaria Bioscience Corp. is a Canadian biotechnology company built around its patented DehydraTECH delivery platform, which uses fatty acid-rich oils to help active ingredients absorb into the bloodstream more efficiently. This improved absorption means medications and other compounds can work better at lower doses, making them easier to tolerate. The technology works across a broad range of substances ? from diabetes and weight-loss drugs to vitamins, hormones, and cannabinoids ? and can be applied to everyday product formats such as tablets, capsules, beverages, and foods.